Fonte: Anais. Nome do evento: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidades: FCF, ICB
Assuntos: NEOPLASIAS, SULFONAMIDAS
ABNT
ALVES, Thais Nascimento de Oliveira et al. Sulfonamide-based benzyl-hydroxamate derivatives as HDAC6i with potential antitumor activity in hematological lineages. 2025, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2025. Disponível em: https://www.sbq.org.br/48ra/anexos/ANAIS-48rasbq.pdf. Acesso em: 07 out. 2025.APA
Alves, T. N. de O., Toledo, M. F. Z. J., Machado Neto, J. A., & Parise Filho, R. (2025). Sulfonamide-based benzyl-hydroxamate derivatives as HDAC6i with potential antitumor activity in hematological lineages. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/48ra/anexos/ANAIS-48rasbq.pdfNLM
Alves TN de O, Toledo MFZJ, Machado Neto JA, Parise Filho R. Sulfonamide-based benzyl-hydroxamate derivatives as HDAC6i with potential antitumor activity in hematological lineages [Internet]. Anais. 2025 ;[citado 2025 out. 07 ] Available from: https://www.sbq.org.br/48ra/anexos/ANAIS-48rasbq.pdfVancouver
Alves TN de O, Toledo MFZJ, Machado Neto JA, Parise Filho R. Sulfonamide-based benzyl-hydroxamate derivatives as HDAC6i with potential antitumor activity in hematological lineages [Internet]. Anais. 2025 ;[citado 2025 out. 07 ] Available from: https://www.sbq.org.br/48ra/anexos/ANAIS-48rasbq.pdf